Low SKP2 expression is predictive of sensitivity to an MDM2 antagonist in p53 wild-type AML. (October 2022) - Kucia-Tran, J.; Bevan, L.; Chessari, G.; Fazal, L.; Ferrari, N.; Lyons, J.; Saini, H.; Wallis, N.; Ward, G.; Ahn, M.